 (JMed Genet 1998;35:727-730) 
The genetic analysis of sex reversed subjects, with a phenotypic sex different from that expected based on the karyotype, has been crucial for the identification of the SRY gene (sex determining region on Y chromosome).
This gene has been proven to be the testicular determinant that causes a switch to the male sex differentiation pathway during fetal life.'S RY mutations have been found in 15% of XY females and 80% of XX males are SRY positive. 46,XX males occur with an incidence of 1/20 000 male neonates.4 Since the first patient was described,' numerous additional cases have been reported, most of them sporadic.'-'0 The clinical manifestations of XX males are usually hypogonadism, gynaecomastia, azoospermia, and hyalinisation of seminiferous tubules, with altered hormonal levels at puberty. Less frequently, some sexual ambiguities are found in these patients, ranging from cryptorchidism and hypospadias to a vaginal pouch, always with sterility owing to reduced testicular development. Male genitalia (internal and external) 46,XX,t(X;Y)(p22.3;pl 1) n + n n n n n n n n n n: not tested. were detected only after the birth of a male following a cytogenetic prenatal diagnosis of 46,XX,34 and where postnatal studies allowed the possibility of a sample error or maternal cell contamination to be ruled out.
Molecular and FISH techniques are very useful for detecting and locating Y sequences in cytogenetically XX males, allowing an accurate diagnosis and correct management of the patient. Testing new Y chromosome markers in XX males will make it possible to narrow the breakpoints further in each case and to establish correlations with the clinical features, identifying the Y regions implicated in the definition of the phenotype.
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